These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 32461211)

  • 21. Limitations of 14-Day Continuous Glucose Monitoring Sampling for Assessment of Hypoglycemia and Glycemic Variability in Type 1 Diabetes.
    Akturk HK
    Diabetes Technol Ther; 2024 Jul; 26(7):503-508. PubMed ID: 38300516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world setting.
    Brett McQueen R; Perez-Nieves M; Todd Alonso G; Fan L; Hankosky ER; Shah VN; Yan Y; Ellis SL; Juneja R
    Diabetes Res Clin Pract; 2024 Jun; 212():111690. PubMed ID: 38697300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal Coefficient of Variance Threshold to Minimize Hypoglycemia Risk in Individuals with Well-Controlled Type 1 Diabetes Mellitus.
    Yoo JH; Yang SH; Jin SM; Kim JH
    Diabetes Metab J; 2024 May; 48(3):429-439. PubMed ID: 38476023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Glycemic Variability Is Associated with Worse Continuous Glucose Monitoring Metrics in Children and Adolescents with Type 1 Diabetes.
    Piona C; Marigliano M; Mozzillo E; Di Candia F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Horm Res Paediatr; 2021; 94(9-10):369-373. PubMed ID: 34915493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes.
    Slattery D; Choudhary P
    Diabetes Technol Ther; 2017 May; 19(S2):S55-S61. PubMed ID: 28541131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Impacts of glycemic variability on the relationship between time in range and estimated glycated hemoglobin in patients with type 1 diabetes mellitus].
    Peng HM; Deng HR; Zhou YW; Wang CF; Lyu J; Mai XD; Yang DZ; Lu J; Xu W; Yan JH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1190-1195. PubMed ID: 35462500
    [No Abstract]   [Full Text] [Related]  

  • 28. "Mind the gap please…": estimated vs. measured A
    Oriot P; Hermans MP
    Acta Clin Belg; 2020 Apr; 75(2):109-115. PubMed ID: 30596337
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment.
    Rizzi A; Tartaglione L; Lucaccini Paoli L; Leo ML; Popolla V; Viti L; Barberio A; Di Leo M; Pontecorvi A; Pitocco D
    Diabetes Obes Metab; 2024 Sep; 26(9):4078-4086. PubMed ID: 39010292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study.
    Charleer S; Mathieu C; Nobels F; De Block C; Radermecker RP; Hermans MP; Taes Y; Vercammen C; T'Sjoen G; Crenier L; Fieuws S; Keymeulen B; Gillard P;
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1224-1232. PubMed ID: 29342264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of glucose management indicator for the estimation of glucose disposal rate in people with type 1 diabetes.
    Cutruzzolà A; Parise M; Scavelli FB; Fiorentino R; Lucà S; Di Molfetta S; Gnasso A; Irace C
    Nutr Metab Cardiovasc Dis; 2024 Oct; 34(10):2344-2352. PubMed ID: 39069471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
    Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
    Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
    [No Abstract]   [Full Text] [Related]  

  • 35. Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.
    Zhu J; Volkening LK; Laffel LM
    Diabetes Care; 2020 Jan; 43(1):22-28. PubMed ID: 31308020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Impaired Awareness of Hypoglycemia on Glucose Decline During and After Exercise in the T1DEXI Study.
    Kamimoto JLJ; Li Z; Gal RL; Castle JR; Doyle FJ; Jacobs PG; Martin CK; Beck RW; Calhoun P; Riddell MC; Rickels MR
    J Clin Endocrinol Metab; 2024 Aug; 109(9):2233-2241. PubMed ID: 38441232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
    Miller KM; Kanapka LG; Rickels MR; Ahmann AJ; Aleppo G; Ang L; Bhargava A; Bode BW; Carlson A; Chaytor NS; Gannon G; Goland R; Hirsch IB; Kiblinger L; Kruger D; Kudva YC; Levy CJ; McGill JB; O'Malley G; Peters AL; Philipson LH; Philis-Tsimikas A; Pop-Busui R; Salam M; Shah VN; Thompson MJ; Vendrame F; Verdejo A; Weinstock RS; Young L; Pratley R
    Diabetes Technol Ther; 2022 Jun; 24(6):424-434. PubMed ID: 35294272
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
    Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
    Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.